Literature DB >> 11739061

A regulatory perspective on psychiatric syndromes in Alzheimer disease.

T Laughren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11739061

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN： 1064-7481            Impact factor:   4.105


× No keyword cloud information.
  11 in total

Review 1.  Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.

Authors:  Sandra S Kindermann; Christian R Dolder; Anne Bailey; Ira R Katz; Dilip V Jeste
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

2.  Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim.

Authors:  Thomas Laughren; Robert Levin
Journal:  Schizophr Bull       Date:  2005-08-03       Impact factor: 9.306

3.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

4.  The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.

Authors:  Philip D Harvey; Michael F Green; Christopher Bowie; Antony Loebel
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

5.  Assessing functional performance using computer-based simulations of everyday activities.

Authors:  Sara J Czaja; David A Loewenstein; Chin Chin Lee; Shih Hua Fu; Philip D Harvey
Journal:  Schizophr Res       Date:  2016-11-30       Impact factor: 4.939

6.  Validation of a Computerized test of Functional Capacity.

Authors:  Richard S E Keefe; Vicki G Davis; Alexandra S Atkins; Adam Vaughan; Tom Patterson; Meera Narasimhan; Philip D Harvey
Journal:  Schizophr Res       Date:  2016-04-16       Impact factor: 4.939

7.  Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.

Authors:  Paula T Trzepacz; Andrew Saykin; Peng Yu; Phani Bhamditipati; Jia Sun; Ellen B Dennehy; Brian Willis; Jeffrey L Cummings
Journal:  Am J Geriatr Psychiatry       Date:  2013-04-18       Impact factor: 4.105

Review 8.  Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.

Authors:  Carl Salzman; Dilip V Jeste; Roger E Meyer; Jiska Cohen-Mansfield; Jeffrey Cummings; George T Grossberg; Lissy Jarvik; Helena C Kraemer; Barry D Lebowitz; Katie Maslow; Bruce G Pollock; Murray Raskind; Susan K Schultz; Philip Wang; Julie M Zito; George S Zubenko
Journal:  J Clin Psychiatry       Date:  2008-06       Impact factor: 4.384

Review 9.  Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches.

Authors:  Philip D Harvey; Christopher R Bowie
Journal:  Psychiatr Clin North Am       Date:  2012-07-15

10.  Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.

Authors:  Jeffrey Cummings; Jacobo Mintzer; Henry Brodaty; Mary Sano; Sube Banerjee; D P Devanand; Serge Gauthier; Robert Howard; Krista Lanctôt; Constantine G Lyketsos; Elaine Peskind; Anton P Porsteinsson; Edgardo Reich; Cristina Sampaio; David Steffens; Marc Wortmann; Kate Zhong
Journal:  Int Psychogeriatr       Date:  2014-10-14       Impact factor: 3.878
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.